AIM ImmunoTech Inc. (AIM) › Total AssetsAIM ImmunoTech Inc. (AIM) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $51.68M2011: $43.51M2012: $57.70M2013: $31.87M2014: $29.44M2015: $22.80M2016: $18.87M2017: $14.21M2018: $13.85M2019: $20.75M2020: $64.58M2021: $57.70M2022: $40.49M2023: $19.38M2024: $8.61M2025: $5.78M$5.78M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$5.78M-32.8%2024$8.61M-55.6%2023$19.38M-52.1%2022$40.49M-29.8%2021$57.70M-10.7%2020$64.58M+211.2%2019$20.75M+49.9%2018$13.85M-2.5%2017$14.21M-24.7%2016$18.87M-17.2%2015$22.80M-22.5%2014$29.44M-7.6%2013$31.87M-44.8%2012$57.70M+32.6%2011$43.51M-15.8%2010$51.68M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share